Josh Riggs
About Josh Riggs
President & Chief Executive Officer of Oncocyte Corporation
Josh Riggs has been serving as President and Chief Executive Officer of Oncocyte Corporation since August 2020. He was appointed Interim Chief Executive Officer in December 2022. Under his leadership, the company focuses on advancing personalized medicine for cancer diagnostics and treatment. Oncocyte Corporation aims to transform cancer care by providing actionable information to guide decisions during diagnosis and treatment.
Business Development and Management at Oncocyte Corporation
Before becoming the President and Chief Executive Officer, Josh Riggs was the Senior Director of Business Development and General Manager for the Transplant division at Oncocyte Corporation. In these roles, he was integral in identifying growth opportunities and managing organizational strategies to expand the company's market reach in the transplant diagnostics sector.
Founder and Principal of Intelliger Consulting
Josh Riggs founded and served as the principal of Intelliger Consulting. The consulting firm focused on consumer-driven healthcare solutions. His work involved advising on innovative healthcare strategies to improve patient engagement and outcomes. His experience in founding and leading a consultancy added valuable entrepreneurial expertise to his professional repertoire.
Principal at Bethesda Group, LLC
Josh Riggs also held the position of principal at Bethesda Group, LLC. In this role, he assisted small and mid-stage diagnostic companies and investment groups in bringing emerging diagnostic content and platforms to the market. His responsibilities included strategic advisement and facilitating market entry for innovative diagnostic technologies.